MARK2 and neoplasm: The Notch co-activator, forkhead box subfamily O1 transcription factor, couples vascular growth with metabolic activity, while Notch signaling triggers the phosphatidylinositol 3-kinase/AKT serine/threonine kinase pathway and regulates glycolysis-related genes during tumor angiogenesis (73, 74).